^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Zanosar (streptozocin)

Company:
Teva
Drug class:
DNA synthesis inhibitor
Related drugs:
2ms
O-GlcNAcylation of ATP-citrate lyase couples glucose supply to lipogenesis for rapid tumor cell proliferation. (PubMed, Proc Natl Acad Sci U S A)
In vivo, streptozocin treatment- and EGFR overexpression-induced growth of xenograft tumors was mitigated once S979 was mutated. Collectively, this work helps comprehend how cells interrogate the nutrient enrichment for proliferation and suggests that although mammalian cell proliferation is controlled by mitogen signaling, the ancient nutrition-sensing mechanism is conserved and still efficacious in the cells of multicellular organisms.
Journal • Tumor cell
|
EGFR (Epidermal growth factor receptor) • ACLY (ATP Citrate Lyase)
|
EGFR overexpression
|
Zanosar (streptozocin)
5ms
The effect of Andaliman (Zanthoxylum acanthopodium DC.) fruit extracted with ethanol on TNF-α and TRPA-1 levels in type II diabetes-induced mice. (PubMed, J Adv Vet Anim Res)
The present study investigated the effects of Andaliman fruit extract on tumor necrosis factor-alpha (TNF-α) and transient receptor potential ankyrin-1 (TRPA-1) levels in type 2 diabetes mellitus (T2DM) mouse models induced with streptozocin (STZ) and a high-fat diet (HFD). In this research, mice were allocated into six distinct groups: normal, negative control (HFD and STZ), positive control (metformin, HFD, and STZ), and three treatment groups (HFD, STZ, and Andaliman extract at varying dosages of 100, 300, and 500 mg/kg, respectively)...Furthermore, Spearman's rho analysis revealed a statistically significant positive association between BGL and both TNF-α and TRPA-1, as well as between TNF-α and TRPA. Andaliman extract potentially serves as a therapy for diabetic neuropathy in T2DM by lowering BGL and inhibiting the expression of TNF-α and TRPA-1.
Preclinical • Journal
|
TNFA (Tumor Necrosis Factor-Alpha)
|
metformin • Zanosar (streptozocin)
5ms
Soluble T-cadherin secretion from endothelial cells is regulated via insulin/PI3K/Akt signalling. (PubMed, Biochem Biophys Res Commun)
We conclude that insulin regulates soluble T-cadherin levels and soluble T-cadherin secretion from endothelial cells is positively regulated by insulin/insulin receptor/Akt signalling.
Journal
|
IR (Insulin receptor) • LEP (Leptin)
|
Zanosar (streptozocin)
5ms
Xiaoke Bitong capsule alleviates inflammatory impairment via inhibition of the TNF signaling pathway to against diabetic peripheral neuropathy. (PubMed, Phytomedicine)
XBC could protect against DPN by inhibiting the release of pro-inflammatory cytokines and regulating the activation of the TNF signaling pathway, further accelerating neurogenesis, and alleviating peripheral nerve lesions. Therefore, this study highlights the therapeutic value of XBC for DPN.
Journal • PARP Biomarker
|
AKT1 (V-akt murine thymoma viral oncogene homolog 1) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • PARP1 (Poly(ADP-Ribose) Polymerase 1) • IL1B (Interleukin 1, beta) • MAPK8 (Mitogen-activated protein kinase 8) • PI3K (Phosphoinositide 3-kinases)
|
Zanosar (streptozocin)
7ms
Acteoside delays the fibrosis process of diabetic nephropathy by anti-oxidation and regulating the autophagy-lysosome pathway. (PubMed, Eur J Pharmacol)
This study aims to investigate the protective effects of ACT on renal interstitial fibrosis in rats with DN induced by intraperitoneal injection of streptozocin (STZ) combined with unilateral nephrectomy and its mechanism. In vivo and in vitro, the effects of ACT on reactive oxygen species (ROS) level, oxidative tubular injury, as well as damage of autophagic flux and lysosome in the DN model were detected. Results indicate that administration of ACT delayed the progression of renal interstitial fibrosis in DN by anti-oxidation and regulating the autophagy-lysosome pathway, which may potentially be attributed to the regulatory influence of ACT on transcription factor EB (TFEB).
Journal
|
TFEB (Transcription Factor EB 2)
|
Zanosar (streptozocin)
7ms
High-glucose conditions attenuate the response of macrophages to Legionella pneumophila infection by inhibiting NOD1 and MAPK signaling. (PubMed, Int Immunopharmacol)
HG attenuates the response of macrophages to LP infection by inhibiting NOD1 upregulation and the activation of MAPK signaling.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • NLRC5 (NLR Family CARD Domain Containing 5) • MAPK8 (Mitogen-activated protein kinase 8) • NOD1 (Nucleotide Binding Oligomerization Domain Containing 1)
|
IL6 expression
|
Zanosar (streptozocin)
8ms
BETTER 2: Two Chemotherapy Regimens Plus or Minus Bevacizumab (clinicaltrials.gov)
P2, N=140, Active, not recruiting, Gustave Roussy, Cancer Campus, Grand Paris | Recruiting --> Active, not recruiting
Enrollment closed
|
Avastin (bevacizumab) • temozolomide • capecitabine • Zanosar (streptozocin)
1year
Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia. (PubMed, Diabetologia)
The present study provides a model of defective counterregulation in a mouse model of type 2 diabetes. It shows that repeated hypoglycaemic episodes induce multiple defects affecting all hypothalamic cell types and their interactions, indicative of impaired neuronal network signalling and dysegulated hypoglycaemia sensing, and displaying features of neurodegenerative diseases. It also shows that repeated hypoglycaemia leads to specific molecular adaptation in the hypothalamus when compared with the cortex.
Preclinical • Journal
|
KCNQ1OT1 (KCNQ1 Opposite Strand/Antisense Transcript 1)
|
Zanosar (streptozocin)
over1year
Conventional Transarterial Chemo embolization Using Streptozocin in Patients with Unresectable Neuroendocrine Liver Metastases. (PubMed, Cancers (Basel))
cTACE using streptozocin is an effective and well-tolerated palliative option for patients with neuroendocrine liver metastases, associated with prolonged survival and delayed time to progression.
Journal
|
Zanosar (streptozocin)
over1year
A case of frequent hypoglycemic attacks successfully controlled with capecitabine plus temozolomide and Lu-DOTATATE peptide receptor radionuclide therapy in a patient with recurrent pancreatic insulinoma. (PubMed, Clin J Gastroenterol)
A 59-year-old woman with metastatic pancreatic insulinoma, having undergone several treatment regimens including sunitinib, everolimus, lanreotide and streptozocin plus 5-fluorouracil, was admitted to our hospital because of frequent hypoglycemic attacks. Computed tomography revealed shrinkage of primary and metastatic lesions, an anti-tumor effect that continued 8 months after treatment was initiated. Hypoglycemic attacks caused by insulinomas are often refractory to conventional therapy; however, combination treatment using CAPTEM and PRRT has demonstrated a positive and significant response, successfully restoring glycemic control.
Journal
|
5-fluorouracil • sunitinib • everolimus • temozolomide • capecitabine • Zanosar (streptozocin)
over1year
The antidiabetic effect of methanolic extract of Holarrhena pubescens seeds is mediated through multiple mechanisms of action. (PubMed, Saudi Pharm J)
It also reduced the serum glucose levels in streptozocin-induced diabetes...The results of the study showed that H. pubescens seed extract increases insulin secretion and inhibits glucose absorption both in-vivo and in-vitro with a weak protein glycation inhibitory effect. The herb is devoid of CYP3A4 inhibitory effect indicating that it may not have pharmacokinetic interaction with the drug metabolized by this enzyme.
Journal
|
Zanosar (streptozocin)
over1year
BETTER 2: Two Chemotherapy Regimens Plus or Minus Bevacizumab (clinicaltrials.gov)
P2, N=140, Recruiting, Gustave Roussy, Cancer Campus, Grand Paris | Trial completion date: Feb 2025 --> Dec 2028 | Trial primary completion date: Jul 2022 --> Dec 2028
Trial completion date • Trial primary completion date
|
Avastin (bevacizumab) • temozolomide • capecitabine • Zanosar (streptozocin)
over1year
Quantitative proteomics combined with network pharmacology analysis unveils the biological basis of Schisandrin B in treating diabetic nephropathy. (PubMed, Comb Chem High Throughput Screen)
Sch functions by relieving oxidative stress and the inflammatory response by regulating Crb3, Xaf1, and Tspan4 protein expression levels to treat DN disease.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL1B (Interleukin 1, beta) • XAF1 (XIAP Associated Factor 1)
|
Zanosar (streptozocin)
2years
Salidroside protects pancreatic β-cells against pyroptosis by regulating the NLRP3/GSDMD pathway in diabetic conditions. (PubMed, Int Immunopharmacol)
Streptozocin-induced DM mice were used to further investigate the effects of SAL on pancreatic pyroptosis...Moreover, SAL administration activated AMPK, suppressed NLRP3/GSDMD signaling, and protected pancreatic β-cells against pyroptosis in DM mice. These findings suggest that SAL promotes AMPK activation to suppress NLRP3/GSDMD-related pyroptosis in pancreatic β-cells under DM conditions.
Journal
|
NLRP3 (NLR Family Pyrin Domain Containing 3)
|
Zanosar (streptozocin)
over2years
Ellagic acid regulates hyperglycemic state through modulation of pancreatic IL-6 and TNF- α immunoexpression. (PubMed, Saudi J Biol Sci)
The aim of this study is to determine the activity of EA on serum α-amylase and lipase titers, and on pancreatic tumor necrosis factor-α (TNF-α), proliferating cell nuclear antigen (PCNA) and interleukin-6 (IL-6) concentrations using the streptozocin-induced T2DM rodent model...Extract of EA has overall tissue reparative and safeguarding properties, as indicated by the augmented β- cell population and enhanced glucose homeostasis. Thus, EA may be an innovative treatment approach for the maintenance of normoglycemia in individuals with T2DM.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • PCNA (Proliferating cell nuclear antigen)
|
IL6 expression
|
Zanosar (streptozocin)
over2years
Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway. (PubMed, Stem Cell Res Ther)
The pretreatment of hUC-MSCs with melatonin partly boosted cell efficiency and thereby alleviated impaired glycemic control and insulin resistance. This study provides a practical strategy to improve the application of hUC-MSCs in diabetes mellitus and cytotherapy. Overview of the PI3K/AKT signaling pathway. (A) Underlying mechanism of UCMSC/Mel inhibition of hyperglycemia and insulin resistance T2DM mice via regulation of PI3K/AKT pathway. hUC-MSCs stimulates glucose uptake and improves insulin action thus should inhibition the clinical signs of T2DM, through activation of the p-PI3K/Akt signaling pathway and then regulates glucose transport through activating AS160. UCMSC/Mel increases p53-dependent expression of BCL2, and inhibit BAX and Capase3 protein activation. Leading to the decrease in apoptosis. (B) Melatonin modulated PI3K/AKT signaling pathway. Melatonin activated PI3K/AKT response pathway through binding to MT1and MT2 receptor. Leading to the increase in hUC-MSCs proliferation, migration and differentiation. → (Direct stimulatory modification); ┴ ( Direct Inhibitory modification); → ┤ (Multistep inhibitory modification); ↑ (Up regulate); ↓ (Down regulate); PI3K (Phosphoinositide 3-Kinase); AKT ( protein kinase B); PDK1 (Phosphoinositide-dependent protein kinase 1); IR, insulin receptor; GLUT4 ( glucose transporter type 4); ROS (reactive oxygen species); BCL-2 (B-cell lymphoma-2); PDK1 (phosphoinositide-dependent kinase 1) BAX (B-cell lymphoma-2-associated X protein); PCNA (Proliferating cell nuclear antigen); Cell cycle-associated proteins (KI67, cyclin A, cyclin E).
Preclinical • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • BAX (BCL2-associated X protein) • CCNA2 (Cyclin A2) • IR (Insulin receptor) • PCNA (Proliferating cell nuclear antigen)
|
BCL2 expression • BAX expression
|
Zanosar (streptozocin)
3years
Green alga Enteromorpha prolifera oligosaccharide ameliorates ageing and hyperglycemia through gut-brain axis in age-matched diabetic mice. (PubMed, Mol Nutr Food Res)
These results suggested that EPO could be a potential novel natural drug for the treatment of diabetes in the elderly.
Preclinical • Journal
|
BCL6 (B-cell CLL/lymphoma 6)
|
Zanosar (streptozocin)
over3years
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3-line treatment. (PubMed, World J Gastroenterol)
Everolimus was the most frequently used therapeutic option in the third-line setting. The most important factors for decision-making included Ki-67, rate of progression, functionality and tumour burden; since this decision is based on multiple factors, it highlights the need for a multidisciplinary assessment.
Journal
|
SSTR (Somatostatin Receptor)
|
5-fluorouracil • everolimus • temozolomide • capecitabine • oxaliplatin • Zanosar (streptozocin)